Koyfin Home > Directory > Health Care > Adamas Pharma > Return on Assets %

Adamas Pharma Return on Assets % Chart (ADMS)

Adamas Pharma annual/quarterly Return on Assets % from 2013 to 2020.
  • Adamas Pharma Return on Assets % for the quarter ending June 06, 2020 was -13.18 a -103.42% increase of 13.63 year over year
  • Adamas Pharma Return on Assets % for the last 12 months ending June 06, 2020 was -23.36 a -15.15% increase of 3.54 year over year
  • Adamas Pharma Annual Return on Assets % for 2019 was -28.45 a -20.07% increase of 5.71 from 2018
  • Adamas Pharma Annual Return on Assets % for 2018 was -34.15 a 2.04% decrease of -0.70 from 2017
  • Adamas Pharma Annual Return on Assets % for 2017 was -33.45 a 15.99% decrease of -5.35 from 2016
Other Margins & Efficiency Metrics:
  • Adamas Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-187m a 135.57% decrease of -254m year over year
  • Adamas Pharma Return on Capital % for the quarter ending September 09, 2018 was -29.66 a -68.05% increase of 20.18 year over year
  • Adamas Pharma Return on Equity % for the quarter ending September 09, 2018 was -103.21 a -49.69% increase of 51.29 year over year
View Chart On Koyfin

Quarterly ADMS Return on Assets % Data

06/2020-13.18
03/2020-21.39
12/2019-31.32
09/2019-26.82
06/2019-25.75
03/2019-29.09
12/2018-25.71
09/2018-26.89
06/2018-26.11
03/2018-32.01

Annual ADMS Return on Assets % Data

2019-28.45
2018-34.15
2017-33.45
2016-28.11
2015-24.76
20149.35
201347.35
201236.46